Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
The Lancet. Microbe|March 29, 2022
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort studyLi Guo, Geng Wang, Yeming Wang, et al.
Cancer Immunology Research|June 20, 2019
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte ResponsesMegat Abd Hamid, Ruo-Zheng Wang, Xuan Yao, et al.
Emerging Microbes & Infections|April 10, 2023
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineagesLi Guo, Qiao Zhang, Jingchuan Zhong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2011
Multilayered defense in HLA-B51-associated HIV viral controlYongHong Zhang, YanChun Peng, HuiPing Yan, et al.
Blood|May 13, 2011
Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural ChinaTao Dong, Yonghong Zhang, Ke Yi Xu, et al.
Plant, Cell & Environment|August 29, 2024
Genomic insights into the modifications of spike morphology traits during wheat breedingYangyang Liu, Rui Yu, Liping Shen, et al.
Cellular & Molecular Immunology|September 4, 2023
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapyQi Chen, Adeline Chia, Shou Kit Hang, et al.
JCI Insight|June 6, 2020
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild diseaseYan Zhao, Ling Qin, Ping Zhang, et al.
Medcomm|November 24, 2025
Impaired Cellular Immunity and Cross-Reactive Humoral Responses to Mpox Virus in HIV-Infected Individuals Vaccinated with Vaccinia Virus Tiantan StrainQiao Zhang, Rui Song, Yu Huang, et al.
Thorax|September 18, 2020
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatmentsNikolaos I Kanellakis, Rachelle Asciak, Megat Abd Hamid, et al.
Pageof 15